Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H3N2 Influenza”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT05163847
What this trial is testing

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Who this might be right for
Influenza Vaccine
FluGen Inc 303
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Testing effectiveness (Phase 2)Study completedNCT01746082
What this trial is testing

Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 211
Early research (Phase 1)Study completedNCT02594189
What this trial is testing

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

Who this might be right for
Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2
National Institute of Allergy and Infectious Diseases (NIAID) 49
Large-scale testing (Phase 3)Active Not RecruitingNCT06087640
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Who this might be right for
Influenza, Human
Seqirus 35,800
Early research (Phase 1)Study completedNCT01498718
What this trial is testing

Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 131
Early research (Phase 1)Study completedNCT03999554
What this trial is testing

Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines

Who this might be right for
Influenza A
FluGen Inc 206
Early research (Phase 1)Ended earlyNCT04960397
What this trial is testing

Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

Who this might be right for
H3N2 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 140
Not applicableStudy completedNCT03743688
What this trial is testing

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaInfluenza, HumanVaccine Reaction+4 more
Vanderbilt University Medical Center 10
Early research (Phase 1)Study completedNCT04785794
What this trial is testing

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Who this might be right for
Influenza Vaccine
FluGen Inc 122
Early research (Phase 1)Study completedNCT00848848
What this trial is testing

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Who this might be right for
Influenza
Seqirus 450
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Post-approval studies (Phase 4)Study completedNCT01246999
What this trial is testing

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Who this might be right for
Influenza
University of Rochester 34
Early research (Phase 1)Looking for participantsNCT06753474
What this trial is testing

A/Texas Flu Challenge

Who this might be right for
Influenza
Emory University 50
Early research (Phase 1)Study completedNCT04978454
What this trial is testing

Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT03883113
What this trial is testing

Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

Who this might be right for
Influenza
Barinthus Biotherapeutics 145
Testing effectiveness (Phase 2)Study completedNCT03315104
What this trial is testing

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

Who this might be right for
Influenza A H3N2Influenza A H1N1
Emergent BioSolutions 65
Not applicableStudy completedNCT04204993
What this trial is testing

Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)

Who this might be right for
Influenza A H3N2
Imperial College London 20
Testing effectiveness (Phase 2)Study completedNCT03220048
What this trial is testing

Study Examining PrEP-001 in Healthy Subjects

Who this might be right for
Influenza A H3N2
Hvivo 66
Early research (Phase 1)Study completedNCT03553940
What this trial is testing

H3N2 M2SR in Pediatric Population

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 43
Load More Results